Blog
RSS FeedPosted by Michael Wonder on 29 Jul 2019
Platelet rich plasma treatment is not classified as a drug, Health Canada says
27 July 2019 - Agency clarifies its position on controversial treatment made popular by superstar athletes. ...
Posted by Michael Wonder on 26 Jul 2019
Federal health minister announces new treatment options for children
25 July 2019 - Health Minister Ginette Petitpas Taylor made the announcement at Health Sciences North in Sudbury on Thursday. ...
Posted by Michael Wonder on 24 Jul 2019
Alnylam launches Onpattro (patisiran) for the treatment of polyneuropathy in hATTR amyloidosis, the first-ever RNAi therapeutic approved in Canada
23 July 2019 - Onpattro is the only treatment that demonstrated improvement, relative to baseline, in both polyneuropathy and quality ...
Posted by Michael Wonder on 17 Jul 2019
Knight Therapeutics announces Health Canada has approved Nerlynx for early-stage breast cancer
16 July 2019 - Knight Therapeutics announced today that Health Canada has approved Nerlynx (neratinib) for the extended adjuvant treatment of ...
Posted by Michael Wonder on 16 Jul 2019
National regulator denied offer to give Canadian physicians training on abortion pill
16 July 2019 - The group representing Canada’s family doctors turned down an offer from a national abortion group to ...
Posted by Michael Wonder on 13 Jul 2019
Esperoct is now approved in Canada for the treatment of haemophilia A in both children and adults
12 July 2019 - New treatment can help Canadians living with haemophilia A better manage their bleeding episodes ...
Posted by Michael Wonder on 11 Jul 2019
Health Canada has authorised Vyvanse (lisdexamphetamine dimesylate), the first and only, chewable tablet for the treatment of attention deficit/hyperactivity disorder
10 July 2019 - Vyvanse offers an additional option for patients who prefer the convenience of a chewable tablet, or who ...
Posted by Michael Wonder on 11 Jul 2019
Health Canada approves Pomalyst-based triplet combination for patients with multiple myeloma
10 July 2019 - Pomalyst in combination with bortezomib and dexamethasone, provides a new medication option for patients living with multiple ...
Posted by Michael Wonder on 19 Jun 2019
Health Canada approves Hemlibra for haemophilia A patients without factor VIII inhibitors
18 June 2019 - Hemlibra is the only treatment that can be self-injected subcutaneously once weekly for patients with hemophilia A ...
Posted by Michael Wonder on 13 Jun 2019
Drug shortages in Canada: why they happen and what you can do about it
12 June 2019 - It’s not entirely unusual for Canadians see warnings emerge over drug shortages in the country. ...
Posted by Michael Wonder on 12 Jun 2019
Sask. Cancer Agency started chemotherapy drug trial without required Health Canada approval
11 June 2019 - Agency says it 'proactively' paused trial 5 months after it started. ...
Posted by Michael Wonder on 11 Jun 2019
Duchesnay is seeking Health Canada's approval for ospemifene for the treatment of moderate to severe dyspareunia and vaginal dryness, symptoms of vulvar and vaginal atrophy, a component of genitourinary syndrome of menopause
10 June 2019 - Duchesnay has filed a new drug submission with Health Canada for a once-daily oral ospemifene tablet, ...
Posted by Michael Wonder on 30 May 2019
Health Canada approves Tecentriq (atezolizumab) combination therapy for first-line treatment of metastatic non-squamous non-small cell lung cancer
29 May 2019 - Data show this new option can help some patients with metastatic non-small cell lung cancer live significantly ...
Posted by Michael Wonder on 30 May 2019
Janssen announces Health Canada approval of Tremfya One-Press (guselkumab) - a patient-controlled injector for adults with moderate-to-severe plaque psoriasis
29 May 2019 - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that Health Canada has approved Tremfya One-Press, ...
Posted by Michael Wonder on 23 May 2019
B.C. eye doctors warn province of spike in glaucoma cases linked to injections of eye drug
23 May 2019 - Thousands of retinal-disease patients in British Columbia are being exposed to an “increased risk of severe ...